Glucosamine Chondroitin MSM Ultra Strength 1,300 mg
Glucosamine Chondroitin MSM Ultra Strength 1,300 mg, NPN 80000269: natural health product licensed in Canada. Medicinal ingredients: Sulfate de 2-amino-2-désoxy-D-glucose, Méthylsulfonylméthane.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Glucosamine sulfate 2KCI from exoskeleton of shrimp and crab | 500 mg | Not calculated |
| Méthylsulfonylméthane | 400 mg | Not calculated |
Non-medicinal ingredients
Glycérol, cellulose, Acide stéarique végétale, Dioxyde de silicium, Talc, Eau purifiée, Croscarmellose de sodium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Caplet | Not specified |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis. Helps relieve the pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and joint health. Helps prevent cartilage deterioration. Joint pain relief associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding.
- Known Adverse Reactions
Some people may experience gastrointestinal discomfort/disturbances.
Product record
- Other names
- Glucosamine Chondroitin MSM, Glucosamine Chondroitin MSM 1,300 mg
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80000269
- Status
- Active licence
- Licence date
- 14 February 2005
- Revision date
- 1 November 2023
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80000269
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Glucosamine Chondroitin MSM Ultra Strength 1,300 mg (Jamieson Laboratories Ltd./ Nutricorp International): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80000269-glucosamine-chondroitin-msm-ultra-strength-1-300-mg, updated 1 November 2023.